Lithuanian President Dalia Grybauskaitė thinks that problems regarding government-subsidized medicines have been "maliciously ignored" until now and that this issue will be a test of confidence for the country' new Health Minister Aurelijus Veryga.
Medicine
© DELFI / Karolina Pansevič

Daiva Ulbinaitė, the president's spokeswoman, said this to reporters after Grybauskaite met with the minister and representatives of supervisory authorities.

According to the spokeswoman, the Health Ministry has until now "maliciously ignored" this problem and there has been "an unjustified inaction".

Reducing medicines prices and increasing the transparency of the system will be "a test of confidence for the new minister", she said.

Also present at the meeting were Juratė Sovienė, deputy chairwoman of the Competition Council, and experts from the National Audit Office who have carried out an audit of the subsidized medicines system.

Parliament committee backs raising corporate tax for banks to 20 pct

The Lithuanian parliamentary Committee on Budget and Finance has backed the proposal to increase the...

Turkish-capital fintech company established in Lithuania

Universal Payment Transfer , a Turkish -capital fintech company, has established a company in...

Lithuanian logistics company moved its governance to Tallinn

DB Schenker , a Lithuanian logistics company , part of German railway company Deutsche Bahn's group,...

Government renounces banking asset tax but proposes additional corporate tax

Lithuania's government is leaning towards "burying" the planned banking asset tax and is proposing...

Lithuania wants Rail Baltica infrastructure to be owned by individual states

Lithuania is seeking that the European standard-gauge railway Rail Baltica 's strategic...